Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Janux Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +1 vs. Q4 2021
- Shares held
- 28.4M
- +891.5K (+3.2%) vs. Q4 2021
- Total value
- $407.1M
- −$134.5M (−24.8%) vs. Q4 2021
- New holders
- 5
- 23 more added
- Sold out
- 4
- 10 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 42 | $1.00K | 0.00% | +42 | New |
| Daiwa Securities Group Inc. | 121 | $2.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,014 | $15.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,092 | $16.0K | 0.00% | −1,860−63.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,242 | $18.0K | 0.00% | −142−10.3% | Reduced |
| Metropolitan Life Insurance Co | 1,382 | $19.8K | 0.00% | −2,629−65.5% | Reduced |
| Legal & General Group Plc | 1,700 | $24.0K | 0.00% | +461+37.2% | Added |
| Citigroup Inc | 1,850 | $27.0K | 0.00% | −2,934−61.3% | Reduced |
| Amalgamated Bank | 1,928 | $28.0K | 0.00% | +1,928 | New |
| Amalgamated Financial Corp. | 1,928 | $28.0K | 0.00% | +1,928 | New |
| Barclays PLC | 2,948 | $42.0K | 0.00% | +2,948 | New |
| UBS Group AG | 3,500 | $50.0K | 0.00% | −185−5.0% | Reduced |
| Wells Fargo & Company | 4,742 | $68.0K | 0.00% | −3,481−42.3% | Reduced |
| Allspring Global Investments Holdings, LLC | 4,742 | $68.0K | 0.00% | −615−11.5% | Reduced |
| California State Teachers Retirement System | 7,579 | $109.0K | 0.00% | +430+6.0% | Added |
| American International Group, Inc. | 8,813 | $126.0K | 0.00% | +1,782+25.3% | Added |
| Deutsche Bank AG | 10,598 | $152.0K | 0.00% | +1,980+23.0% | Added |
| MetLife Investment Management | 10,614 | $152.2K | 0.00% | +5,312+100.2% | Added |
| D. E. Shaw & Co., Inc. | 11,480 | $165.0K | 0.00% | −16,291−58.7% | Reduced |
| New York State Common Retirement Fund | 15,521 | $223.0K | 0.00% | +6,000+63.0% | Added |
| Rhumbline Advisers | 16,216 | $233.0K | 0.00% | +5,179+46.9% | Added |
| State of Wisconsin Investment Board | 17,700 | $254.0K | 0.00% | +17,700 | New |
| JPMorgan Chase & Co | 17,926 | $256.0K | 0.00% | +4,638+34.9% | Added |
| Goldman Sachs Group Inc | 17,934 | $257.0K | 0.00% | +3,186+21.6% | Added |
| Nuveen Asset Management, LLC | 25,660 | $392.0K | 0.00% | +6,203+31.9% | Added |
| Morgan Stanley | 27,743 | $398.0K | 0.00% | +13,264+91.6% | Added |
| Parkwood LLC | 28,258 | $405.0K | 0.07% | −3,870−12.0% | Reduced |
| Bank of America Corp | 41,159 | $590.0K | 0.00% | +33,525+439.2% | Added |
| Charles Schwab Investment Management Inc | 44,400 | $637.0K | 0.00% | +10,454+30.8% | Added |
| Bank of New York Mellon Corp | 46,001 | $660.0K | 0.00% | +9,464+25.9% | Added |
| Northern Trust Corp | 140,247 | $2.01M | 0.00% | +24,752+21.4% | Added |
| Cerity Partners LLC | 150,933 | $2.16M | 0.03% | 00.0% | Unchanged |
| State Street Corp | 241,998 | $3.47M | 0.00% | +30,432+14.4% | Added |
| Geode Capital Management, LLC | 275,231 | $3.95M | 0.00% | +54,704+24.8% | Added |
| Woodline Partners LP | 278,323 | $3.99M | 0.07% | +480.0% | Added |
| Adage Capital Partners GP, L.L.C. | 400,000 | $5.74M | 0.01% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 411,871 | $5.91M | 1.49% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 446,266 | $6.40M | 1.40% | 00.0% | Unchanged |
| Vanguard Group Inc | 565,979 | $8.12M | 0.00% | +32,908+6.2% | Added |
| BVF Inc | 1,142,340 | $16.4M | 0.66% | +125,026+12.3% | Added |
| BlackRock Inc. | 1,161,721 | $16.7M | 0.00% | +153,460+15.2% | Added |
| EcoR1 Capital, LLC | 1,421,319 | $20.4M | 0.64% | +9,344+0.7% | Added |
| Citadel Advisors LLC | 1,853,432 | $26.6M | 0.03% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,339,146 | $33.5M | 0.02% | −61,747−2.6% | Reduced |
| OrbiMed Advisors LLC | 2,836,386 | $40.7M | 0.66% | 00.0% | Unchanged |
| FMR LLC | 5,676,926 | $81.4M | 0.01% | +685,524+13.7% | Added |
| Ra Capital Management, L.P. | 8,670,644 | $124.3M | 2.71% | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −185,196−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,746−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −11,380−100.0% | Sold out |